Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.680
0.00 (0.00%)
Apr 28, 2025, 12:00 PM EDT - Market open
Aerovate Therapeutics Market Cap
Aerovate Therapeutics has a market cap or net worth of $77.68 million as of April 28, 2025. Its market cap has decreased by -89.68% in one year.
Market Cap
77.68M
Enterprise Value
1.78M
1-Year Change
-89.68%
Ranking
Category
Stock Price
$2.68
Market Cap Chart
Since the IPO on June 30, 2021, Aerovate Therapeutics's market cap has decreased from $323.51M to $77.68M, a decrease of -75.99%. That is a compound annual growth rate of -31.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 77.68M | 1.52% |
| Dec 31, 2024 | 76.52M | -87.78% |
| Dec 29, 2023 | 626.15M | -13.15% |
| Dec 30, 2022 | 720.93M | 150.50% |
| Dec 31, 2021 | 287.80M | -11.04% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |